Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest InSightec Ltd. Stories

2014-04-13 16:20:11

TEL AVIV, Israel, April 13, 2014 /PRNewswire/ -- Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today that Elbit Medical Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M), a subsidiary of the Company in which it holds approximately 86% of the voting power, announced that on March 25, 2014, InSightec Ltd. ("InSightec"), in which Elbit Medical holds approximately 48.2% of the share capital (approximately 42.3% on a fully diluted basis), has notified Elbit...

2013-11-07 08:30:59

TIRAT CARMEL, Israel, November 7, 2013 /PRNewswire/ -- InSightec [http://us.insightec.com ] Ltd, the leader in MRI guided Focused Ultrasound therapy, announced that Robert Sigal, MD, PhD, will be joining InSightec as President and Chief Commercial Officer as of October 13, 2013. He will be responsible for all the commercial aspects of InSightec reporting to Dr. Kobi Vortman, CEO and Founder of InSightec Ltd. Robert, who holds an MD from Cochin Medical School, Paris, and...

2013-09-10 08:32:02

The BIRD Foundation will support InSightec and the Focused Ultrasound Foundation in this study of scalpel-free brain surgery TIRAT CARMEL, Israel, September 10, 2013 /PRNewswire/ -- InSightec Ltd, the global leader in MR guided focused ultrasound, announced that the first patient has been treated as part of an ExAblate Neuro Phase III pivotal trial. The trial is a multicenter, double-blinded, randomized study to evaluate the efficacy and safety of treatment using the ExAblate...

2013-08-22 08:27:00

Third generation ExAblate system, using non-invasive MR guided Focused Ultrasound (MRgFUS) now available for Canadian patients TIRAT CARMEL, Israel, August 22, 2013 /PRNewswire/ -- InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that its ExAblate system received approval of Health Canada for MRgFUS treatment of uterine fibroids and for pain palliation of bone metastases. ExAblate combines high intensity focused ultrasound waves and continuous...

2013-07-29 04:21:12

TIRAT CARMEL, Israel, July 29, 2013 /PRNewswire/ -- Non-invasive MR guided Focused Ultrasound treatment now available for millions of Chinese women suffering from uterine fibroids InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that its ExAblate system received approval of the Chinese Food and Drug Administration (CFDA) for non-invasive treatment of uterine fibroids. Uterine fibroids are benign tumors that...

2013-04-18 08:32:50

TIRAT CARMEL, Israel, April 18, 2013 /PRNewswire/ -- InSightec Ltd. announced today that the US Centers for Medicare & Medicaid Services (CMS), a federal agency within the US Department of Health and Human Services (HHS), has created a new billing code for MR guided focused ultrasound treatment of pain palliation of metastatic bone lesions and has established a Medicare payment rate for hospital outpatient departments. InSightec's ExAblate received Food and Drug...

2013-02-19 08:34:24

TIRAT CARMEL, Israel, February 19, 2013 /PRNewswire/ -- InSightec Ltd announced that it has received FDA approval to begin its pivotal Phase III clinical trial for treatment of essential tremor using ExAblate(R) Neuro. This trial is intended to provide the safety and effectiveness data about the use of ExAblate(R) Neuro in order to support FDA pre-marketing approval. ExAblate Neuro uses MR guided focused ultrasound therapy to provide an incision-less treatment, through...

2012-12-04 08:28:04

TIRAT CARMEL, Israel, December 4, 2012 /PRNewswire/ -- ExAblate treatment is indicated for use for essential tremor, tremor dominant Parkinson's disease and neuropathic pain InSightec Ltd. announced that its transcranial focused ultrasound system, ExAblate Neuro, has been awarded the European CE mark for the treatment of neurological disorders in the brain including essential tremor, Parkinson's disease and neuropathic pain. Millions...

2012-12-04 04:21:51

TEL AVIV, Israel, December 4, 2012 /PRNewswire/ -- Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today that on December 3, 2012, Elbit Medical Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M) (in which the Company holds approximately 90%), announced that InSightec Ltd. ("InSightec") (in which Elbit Medical holds approximately 64%, and 52.15% on a fully diluted basis) has been awarded the European CE mark for its transcranial focused ultrasound...

2012-10-22 07:29:06

TIRAT CARMEL, Israel, October 22, 2012 /PRNewswire/ -- InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate(R) MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it...